Biostax Corp (BTAX)

[Bigwitz]

$TNIB...



from PR Statement.
PR Newswire TNI BioTech, Inc.
July 14, 2014 3:17 PM


"Cytocom, Inc., has received interest from two investment banking firms to underwrite and fund Cytocom pursuant to a S-1 Registration Statement that would fund the company's development plan.

"Upon the spin-off, Cytocom will be able to focus on its development stage, targeted immunology and oncology pipeline and once spin-off and distribution is complete, Cytocom will operate as a stand-alone publicly traded company," said Dr. Graham Burton President and CEO of Cytocom."